Apr 3 |
UPDATE 2-Lilly's weight-loss drug Zepbound to face supply crunch through April-end, US FDA says
|
Apr 3 |
Unpacking the Latest Options Trading Trends in Eli Lilly and Co
|
Apr 3 |
Novo’s Ozempic to face copycats as Chinese firm seeks biosimilar nod
|
Apr 3 |
Costco Long Known For Rotisserie Chicken And Hot Dogs Counters Junk Food With Weight Loss Plan To Help You Shed Those Extras
|
Apr 2 |
Dow Jones Futures: Market Holds Key Levels, Meta Eyes Buy Point; Tesla Skids On 'Unmitigated Disaster'
|
Apr 2 |
Stocks Bend As Yields Rise; Meta Platforms, Uber, Eli Lilly In Focus
|
Apr 2 |
Some doses of Lilly's Mounjaro in tight supply through April, US FDA says
|
Apr 2 |
UPDATE 1-Some doses of Lilly's Mounjaro in tight supply through April, US FDA says
|
Apr 2 |
Eli Lilly Stock Navigates Weight-Loss Drug Competition With Technical Resilience
|
Apr 2 |
FDA website shows limited availability of some doses of Lilly's Mounjaro through April
|